{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:19:06Z","timestamp":1787051946473,"version":"build-2736575974"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T00:00:00Z","timestamp":1331596800000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbiology and Immunology"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The aims of this study were to elucidate the kinetics of Epstein\u2010Barr virus (EBV) DNA load in serially collected peripheral blood mononuclear cells of patients with primary EBV infection, and to determine the correlated host factors. Blood samples were collected from 24 patients with primary EBV infection. EBV DNA copy numbers were measured using real\u2010time polymerase chain reaction. Based on the kinetics of EBV DNA load, the 24 patients were divided into two groups: rapid regression and slow regression. Eighteen of the 24 patients (75%) were included in the slow regression and 6 (25%) in the rapid regression group. No statistically significant differences were observed between the two groups in clinical features and laboratory findings. However, acute phase (3 to 10 days after the onset of the illness) serum samples from six children in the slow regression and four in the rapid regression group revealed significantly higher serum interleukin (IL)\u20101\u03b2 (<jats:italic>P<\/jats:italic>= 0.018), IL\u201012 (<jats:italic>P<\/jats:italic>= 0.009), tumor necrosis factor\u2010\u03b1 (<jats:italic>P<\/jats:italic>= 0.019), interferon\u2010inducible protein 10, and monokine induced by interferon \u03b3 concentrations in the rapid regression than the slow regression group. On the other hand, sera from six children in the slow regression and four in the rapid regression group in the convalescent phase (14 to 21 days after the onset of the illness) showed no statistically significant differences between the two groups in these biomarker concentrations. Based on this, it was concluded that the kinetics of EBV DNA load can be divided to two different patterns after primary EBV infection, and immune response might be associated with viral clearance.<\/jats:p>","DOI":"10.1111\/j.1348-0421.2011.00410.x","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T08:50:33Z","timestamp":1323420633000},"page":"93-98","source":"Crossref","is-referenced-by-count":9,"title":["Host factors associated with the kinetics of Epstein\u2010Barr virus DNA load in patients with primary Epstein\u2010Barr virus infection"],"prefix":"10.1111","volume":"56","author":[{"given":"Hidetaka","family":"Nakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sugata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshizo","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomochika","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/CMR.00006-09","article-title":"Using Epstein\u2010Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder","volume":"23","author":"Gulley M.L.","journal-title":"Clin Microbiol Rev"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702492"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2004.00073.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02789.x"},{"key":"e_1_2_8_6_2","first-page":"216","article-title":"Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein\u2010Barr virus\u2010associated infectious mononucleosis","volume":"40","author":"Cheng C.C.","year":"2007","journal-title":"J Microbiol, Immunol Infect = Wei mian yu gan ran za zhi"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.1.132-136.1999"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(02)00333-2"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000078157.90639.96"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1078"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.6.1095"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82200-0"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/491740"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/421276"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/500248"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05452.x"},{"key":"e_1_2_8_17_2","first-page":"263","article-title":"High Th1\u2010type cytokine serum levels in patients with infectious mononucleosis","volume":"48","author":"Corsi M.M.","year":"2004","journal-title":"Acta Virol"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809057570"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/314883"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/322987"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05875.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1297-1346"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0291"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65119-X"}],"container-title":["Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1348-0421.2011.00410.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1348-0421.2011.00410.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T06:06:01Z","timestamp":1698645961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1348-0421.2011.00410.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1348-0421.2011.00410.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1348-0421.2011.00410.x","archive":["Portico"],"relation":{},"ISSN":["0385-5600","1348-0421"],"issn-type":[{"value":"0385-5600","type":"print"},{"value":"1348-0421","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}